Primary biliary cirrhosis--presentation and diagnosis.

Area of Science:

• Hepatology
• Immunology
• Gastroenterology

Background:

• Primary biliary cirrhosis (PBC) is a chronic autoimmune liver disease predominantly affecting middle-aged women.
• Symptoms include fatigue, pruritus, and abdominal pain, with jaundice appearing in end-stage disease.
• Associated conditions like Sjögren's syndrome and autoimmune thyroiditis are common.

Purpose of the Study:

• To summarize the key aspects of primary biliary cirrhosis, including its presentation, diagnosis, and prognosis.
• To highlight the diagnostic criteria and histological staging of PBC.
• To discuss associated conditions and potential complications such as hepatocellular carcinoma.

Main Methods:

• Diagnosis is established through a combination of antimitochondrial antibodies (AMA), cholestatic liver enzyme patterns, and liver histology.
• AMA-negative cases may be diagnosed using antinuclear antibodies (ANA) or other autoantibodies.
• Liver histology is crucial for staging, identifying four distinct stages from early bile duct lesions to cirrhosis.

Main Results:

• Cholestatic indices, including elevated alkaline phosphatase and gammaglutamyltransferase, are characteristic but do not correlate with disease progression.
• Serum bilirubin is the sole prognostic factor in PBC.
• Hepatocellular carcinoma is a rare complication, more frequent in men than women.

Conclusions:

• PBC diagnosis requires a triad of AMA, cholestatic indices, and compatible liver histology.
• Liver histology is essential for diagnosis and staging, with four stages identified.
• While AMA is a key diagnostic marker, AMA-negative PBC patients share similar biochemical profiles but may have higher ANA, SMA, and IgG levels.